nodes	percent_of_prediction	percent_of_DWPC	metapath
Bepridil—hypertension—type 2 diabetes mellitus	0.351	1	CtDrD
Bepridil—KCNQ1—type 2 diabetes mellitus	0.197	0.677	CbGaD
Bepridil—Tripelennamine—Rosiglitazone—type 2 diabetes mellitus	0.11	1	CrCrCtD
Bepridil—CALM1—type 2 diabetes mellitus	0.0938	0.323	CbGaD
Bepridil—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0146	0.176	CbGbCtD
Bepridil—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.013	0.157	CbGbCtD
Bepridil—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00939	0.113	CbGbCtD
Bepridil—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00885	0.107	CbGbCtD
Bepridil—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00816	0.0987	CbGbCtD
Bepridil—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0067	0.081	CbGbCtD
Bepridil—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00645	0.078	CbGbCtD
Bepridil—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00643	0.0777	CbGbCtD
Bepridil—ABCB1—Glyburide—type 2 diabetes mellitus	0.00481	0.0581	CbGbCtD
Bepridil—ABCB1—Losartan—type 2 diabetes mellitus	0.0044	0.0531	CbGbCtD
Bepridil—CACNA1A—nerve—type 2 diabetes mellitus	0.00188	0.0667	CbGeAlD
Bepridil—CALM1—sympathetic nervous system—type 2 diabetes mellitus	0.00142	0.0502	CbGeAlD
Bepridil—CALM1—autonomic nervous system—type 2 diabetes mellitus	0.000954	0.0338	CbGeAlD
Bepridil—CACNA1A—islet of Langerhans—type 2 diabetes mellitus	0.000913	0.0323	CbGeAlD
Bepridil—CALM2—peripheral nervous system—type 2 diabetes mellitus	0.000692	0.0245	CbGeAlD
Bepridil—CALM1—peripheral nervous system—type 2 diabetes mellitus	0.000688	0.0244	CbGeAlD
Bepridil—CACNA2D2—islet of Langerhans—type 2 diabetes mellitus	0.000643	0.0227	CbGeAlD
Bepridil—KCNQ1—islet of Langerhans—type 2 diabetes mellitus	0.000621	0.022	CbGeAlD
Bepridil—TNNC1—cardiovascular system—type 2 diabetes mellitus	0.000552	0.0195	CbGeAlD
Bepridil—CALM2—artery—type 2 diabetes mellitus	0.000544	0.0192	CbGeAlD
Bepridil—CALM1—artery—type 2 diabetes mellitus	0.000541	0.0191	CbGeAlD
Bepridil—CALM2—nerve—type 2 diabetes mellitus	0.000539	0.0191	CbGeAlD
Bepridil—PDE1A—nephron tubule—type 2 diabetes mellitus	0.000537	0.019	CbGeAlD
Bepridil—CALM1—nerve—type 2 diabetes mellitus	0.000537	0.019	CbGeAlD
Bepridil—PDE1B—adipose tissue—type 2 diabetes mellitus	0.000508	0.018	CbGeAlD
Bepridil—TNNC1—adipose tissue—type 2 diabetes mellitus	0.000487	0.0172	CbGeAlD
Bepridil—PDE1A—cardiovascular system—type 2 diabetes mellitus	0.000483	0.0171	CbGeAlD
Bepridil—PDE1A—kidney—type 2 diabetes mellitus	0.000472	0.0167	CbGeAlD
Bepridil—PDE1A—cortex of kidney—type 2 diabetes mellitus	0.00046	0.0163	CbGeAlD
Bepridil—CALM2—endothelium—type 2 diabetes mellitus	0.000459	0.0162	CbGeAlD
Bepridil—CALM1—endothelium—type 2 diabetes mellitus	0.000457	0.0162	CbGeAlD
Bepridil—KCNQ1—cardiovascular system—type 2 diabetes mellitus	0.000449	0.0159	CbGeAlD
Bepridil—KCNQ1—kidney—type 2 diabetes mellitus	0.000439	0.0155	CbGeAlD
Bepridil—KCNQ1—pancreas—type 2 diabetes mellitus	0.000436	0.0154	CbGeAlD
Bepridil—CACNA1D—islet of Langerhans—type 2 diabetes mellitus	0.00043	0.0152	CbGeAlD
Bepridil—KCNQ1—cortex of kidney—type 2 diabetes mellitus	0.000428	0.0151	CbGeAlD
Bepridil—PDE1A—adipose tissue—type 2 diabetes mellitus	0.000426	0.0151	CbGeAlD
Bepridil—KCNQ1—adipose tissue—type 2 diabetes mellitus	0.000396	0.014	CbGeAlD
Bepridil—CACNA1H—cardiovascular system—type 2 diabetes mellitus	0.000377	0.0133	CbGeAlD
Bepridil—CALM3—islet of Langerhans—type 2 diabetes mellitus	0.000333	0.0118	CbGeAlD
Bepridil—CACNA1D—cardiovascular system—type 2 diabetes mellitus	0.000311	0.011	CbGeAlD
Bepridil—CACNA1D—pancreas—type 2 diabetes mellitus	0.000302	0.0107	CbGeAlD
Bepridil—PDE1A—liver—type 2 diabetes mellitus	0.000299	0.0106	CbGeAlD
Bepridil—ATP1A1—islet of Langerhans—type 2 diabetes mellitus	0.000297	0.0105	CbGeAlD
Bepridil—CACNA1C—cardiovascular system—type 2 diabetes mellitus	0.000287	0.0102	CbGeAlD
Bepridil—CALM3—retina—type 2 diabetes mellitus	0.000284	0.0101	CbGeAlD
Bepridil—KCNQ1—liver—type 2 diabetes mellitus	0.000278	0.00982	CbGeAlD
Bepridil—CALM3—nephron tubule—type 2 diabetes mellitus	0.000268	0.00947	CbGeAlD
Bepridil—CALM2—islet of Langerhans—type 2 diabetes mellitus	0.000261	0.00924	CbGeAlD
Bepridil—CALM1—islet of Langerhans—type 2 diabetes mellitus	0.00026	0.0092	CbGeAlD
Bepridil—ATP1A1—retina—type 2 diabetes mellitus	0.000254	0.00897	CbGeAlD
Bepridil—CACNA1C—adipose tissue—type 2 diabetes mellitus	0.000253	0.00896	CbGeAlD
Bepridil—ATP1A1—nephron tubule—type 2 diabetes mellitus	0.000239	0.00845	CbGeAlD
Bepridil—KCNH2—islet of Langerhans—type 2 diabetes mellitus	0.000237	0.00837	CbGeAlD
Bepridil—CALM3—pancreas—type 2 diabetes mellitus	0.000234	0.00827	CbGeAlD
Bepridil—CACNA1H—liver—type 2 diabetes mellitus	0.000233	0.00825	CbGeAlD
Bepridil—CALM3—cortex of kidney—type 2 diabetes mellitus	0.000229	0.00811	CbGeAlD
Bepridil—CALM2—retina—type 2 diabetes mellitus	0.000223	0.0079	CbGeAlD
Bepridil—CALM1—retina—type 2 diabetes mellitus	0.000222	0.00786	CbGeAlD
Bepridil—ATP1A1—cardiovascular system—type 2 diabetes mellitus	0.000214	0.00759	CbGeAlD
Bepridil—CALM3—adipose tissue—type 2 diabetes mellitus	0.000212	0.0075	CbGeAlD
Bepridil—CALM2—nephron tubule—type 2 diabetes mellitus	0.00021	0.00744	CbGeAlD
Bepridil—ATP1A1—kidney—type 2 diabetes mellitus	0.00021	0.00743	CbGeAlD
Bepridil—CALM1—nephron tubule—type 2 diabetes mellitus	0.000209	0.00741	CbGeAlD
Bepridil—ATP1A1—pancreas—type 2 diabetes mellitus	0.000208	0.00738	CbGeAlD
Bepridil—ATP1A1—cortex of kidney—type 2 diabetes mellitus	0.000204	0.00723	CbGeAlD
Bepridil—CACNA1D—liver—type 2 diabetes mellitus	0.000192	0.00681	CbGeAlD
Bepridil—ATP1A1—adipose tissue—type 2 diabetes mellitus	0.000189	0.00669	CbGeAlD
Bepridil—CALM2—cardiovascular system—type 2 diabetes mellitus	0.000189	0.00668	CbGeAlD
Bepridil—CALM1—cardiovascular system—type 2 diabetes mellitus	0.000188	0.00665	CbGeAlD
Bepridil—CALM2—kidney—type 2 diabetes mellitus	0.000185	0.00654	CbGeAlD
Bepridil—CALM1—kidney—type 2 diabetes mellitus	0.000184	0.00651	CbGeAlD
Bepridil—CALM2—pancreas—type 2 diabetes mellitus	0.000184	0.0065	CbGeAlD
Bepridil—CALM1—pancreas—type 2 diabetes mellitus	0.000183	0.00647	CbGeAlD
Bepridil—CALM2—cortex of kidney—type 2 diabetes mellitus	0.00018	0.00637	CbGeAlD
Bepridil—CALM1—cortex of kidney—type 2 diabetes mellitus	0.000179	0.00634	CbGeAlD
Bepridil—KCNH2—cardiovascular system—type 2 diabetes mellitus	0.000171	0.00605	CbGeAlD
Bepridil—Phenoxybenzamine—CALM1—type 2 diabetes mellitus	0.000168	0.322	CrCbGaD
Bepridil—CALM2—adipose tissue—type 2 diabetes mellitus	0.000167	0.00589	CbGeAlD
Bepridil—CALM1—adipose tissue—type 2 diabetes mellitus	0.000166	0.00587	CbGeAlD
Bepridil—CALM3—liver—type 2 diabetes mellitus	0.000149	0.00526	CbGeAlD
Bepridil—ATP1A1—liver—type 2 diabetes mellitus	0.000133	0.00469	CbGeAlD
Bepridil—CALM2—liver—type 2 diabetes mellitus	0.000117	0.00413	CbGeAlD
Bepridil—CALM1—liver—type 2 diabetes mellitus	0.000116	0.00411	CbGeAlD
Bepridil—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000104	0.00367	CbGeAlD
Bepridil—CYP2D6—kidney—type 2 diabetes mellitus	0.000102	0.00361	CbGeAlD
Bepridil—ABCB1—retina—type 2 diabetes mellitus	8.87e-05	0.00314	CbGeAlD
Bepridil—Cough—Valsartan—type 2 diabetes mellitus	8.56e-05	0.00122	CcSEcCtD
Bepridil—Nausea—Rosiglitazone—type 2 diabetes mellitus	8.56e-05	0.00122	CcSEcCtD
Bepridil—Dyspepsia—Glyburide—type 2 diabetes mellitus	8.55e-05	0.00122	CcSEcCtD
Bepridil—Tinnitus—Losartan—type 2 diabetes mellitus	8.5e-05	0.00122	CcSEcCtD
Bepridil—Cough—Orlistat—type 2 diabetes mellitus	8.46e-05	0.00121	CcSEcCtD
Bepridil—Asthenia—Glimepiride—type 2 diabetes mellitus	8.45e-05	0.00121	CcSEcCtD
Bepridil—Decreased appetite—Glyburide—type 2 diabetes mellitus	8.44e-05	0.00121	CcSEcCtD
Bepridil—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	8.43e-05	0.00121	CcSEcCtD
Bepridil—Vision blurred—Metformin—type 2 diabetes mellitus	8.42e-05	0.0012	CcSEcCtD
Bepridil—Asthenia—Sitagliptin—type 2 diabetes mellitus	8.42e-05	0.0012	CcSEcCtD
Bepridil—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	8.4e-05	0.0012	CcSEcCtD
Bepridil—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	8.4e-05	0.0012	CcSEcCtD
Bepridil—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	8.38e-05	0.0012	CcSEcCtD
Bepridil—Tremor—Metformin—type 2 diabetes mellitus	8.37e-05	0.0012	CcSEcCtD
Bepridil—ABCB1—nephron tubule—type 2 diabetes mellitus	8.36e-05	0.00296	CbGeAlD
Bepridil—Myalgia—Valsartan—type 2 diabetes mellitus	8.35e-05	0.00119	CcSEcCtD
Bepridil—Sweating—Ramipril—type 2 diabetes mellitus	8.35e-05	0.00119	CcSEcCtD
Bepridil—Dizziness—Glipizide—type 2 diabetes mellitus	8.34e-05	0.00119	CcSEcCtD
Bepridil—Anxiety—Valsartan—type 2 diabetes mellitus	8.33e-05	0.00119	CcSEcCtD
Bepridil—Flatulence—Irbesartan—type 2 diabetes mellitus	8.31e-05	0.00119	CcSEcCtD
Bepridil—Tension—Irbesartan—type 2 diabetes mellitus	8.28e-05	0.00118	CcSEcCtD
Bepridil—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	8.27e-05	0.00118	CcSEcCtD
Bepridil—Myalgia—Orlistat—type 2 diabetes mellitus	8.26e-05	0.00118	CcSEcCtD
Bepridil—Anxiety—Orlistat—type 2 diabetes mellitus	8.23e-05	0.00118	CcSEcCtD
Bepridil—Nervousness—Irbesartan—type 2 diabetes mellitus	8.19e-05	0.00117	CcSEcCtD
Bepridil—Dry mouth—Valsartan—type 2 diabetes mellitus	8.17e-05	0.00117	CcSEcCtD
Bepridil—Arrhythmia—Losartan—type 2 diabetes mellitus	8.14e-05	0.00116	CcSEcCtD
Bepridil—Dry mouth—Orlistat—type 2 diabetes mellitus	8.07e-05	0.00115	CcSEcCtD
Bepridil—Diarrhoea—Glimepiride—type 2 diabetes mellitus	8.05e-05	0.00115	CcSEcCtD
Bepridil—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	8.03e-05	0.00115	CcSEcCtD
Bepridil—Syncope—Metformin—type 2 diabetes mellitus	8.01e-05	0.00115	CcSEcCtD
Bepridil—Oedema—Valsartan—type 2 diabetes mellitus	8.01e-05	0.00115	CcSEcCtD
Bepridil—Dizziness—Pioglitazone—type 2 diabetes mellitus	7.99e-05	0.00114	CcSEcCtD
Bepridil—Benzphetamine—ADRA2A—type 2 diabetes mellitus	7.96e-05	0.152	CrCbGaD
Bepridil—Rash—Glipizide—type 2 diabetes mellitus	7.95e-05	0.00114	CcSEcCtD
Bepridil—Vision blurred—Irbesartan—type 2 diabetes mellitus	7.95e-05	0.00114	CcSEcCtD
Bepridil—Dermatitis—Glipizide—type 2 diabetes mellitus	7.95e-05	0.00114	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	7.94e-05	0.00114	CcSEcCtD
Bepridil—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	7.94e-05	0.00114	CcSEcCtD
Bepridil—Oedema—Orlistat—type 2 diabetes mellitus	7.91e-05	0.00113	CcSEcCtD
Bepridil—Headache—Glipizide—type 2 diabetes mellitus	7.9e-05	0.00113	CcSEcCtD
Bepridil—Tremor—Irbesartan—type 2 diabetes mellitus	7.9e-05	0.00113	CcSEcCtD
Bepridil—Palpitations—Metformin—type 2 diabetes mellitus	7.9e-05	0.00113	CcSEcCtD
Bepridil—Insomnia—Gliclazide—type 2 diabetes mellitus	7.88e-05	0.00113	CcSEcCtD
Bepridil—Shock—Valsartan—type 2 diabetes mellitus	7.88e-05	0.00113	CcSEcCtD
Bepridil—Loss of consciousness—Metformin—type 2 diabetes mellitus	7.85e-05	0.00112	CcSEcCtD
Bepridil—Paraesthesia—Gliclazide—type 2 diabetes mellitus	7.83e-05	0.00112	CcSEcCtD
Bepridil—Flatulence—Losartan—type 2 diabetes mellitus	7.82e-05	0.00112	CcSEcCtD
Bepridil—Tension—Losartan—type 2 diabetes mellitus	7.79e-05	0.00111	CcSEcCtD
Bepridil—Dizziness—Glimepiride—type 2 diabetes mellitus	7.78e-05	0.00111	CcSEcCtD
Bepridil—Dyspnoea—Gliclazide—type 2 diabetes mellitus	7.77e-05	0.00111	CcSEcCtD
Bepridil—Dizziness—Sitagliptin—type 2 diabetes mellitus	7.76e-05	0.00111	CcSEcCtD
Bepridil—Somnolence—Gliclazide—type 2 diabetes mellitus	7.75e-05	0.00111	CcSEcCtD
Bepridil—Hypertension—Metformin—type 2 diabetes mellitus	7.72e-05	0.0011	CcSEcCtD
Bepridil—Nervousness—Losartan—type 2 diabetes mellitus	7.71e-05	0.0011	CcSEcCtD
Bepridil—Abdominal pain—Glyburide—type 2 diabetes mellitus	7.67e-05	0.0011	CcSEcCtD
Bepridil—Dyspepsia—Gliclazide—type 2 diabetes mellitus	7.67e-05	0.0011	CcSEcCtD
Bepridil—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	7.65e-05	0.00109	CcSEcCtD
Bepridil—Anorexia—Valsartan—type 2 diabetes mellitus	7.63e-05	0.00109	CcSEcCtD
Bepridil—Asthenia—Bromocriptine—type 2 diabetes mellitus	7.62e-05	0.00109	CcSEcCtD
Bepridil—Myalgia—Metformin—type 2 diabetes mellitus	7.61e-05	0.00109	CcSEcCtD
Bepridil—Phenoxybenzamine—ADRA2A—type 2 diabetes mellitus	7.6e-05	0.146	CrCbGaD
Bepridil—Vertigo—Irbesartan—type 2 diabetes mellitus	7.58e-05	0.00108	CcSEcCtD
Bepridil—Headache—Pioglitazone—type 2 diabetes mellitus	7.57e-05	0.00108	CcSEcCtD
Bepridil—Syncope—Irbesartan—type 2 diabetes mellitus	7.56e-05	0.00108	CcSEcCtD
Bepridil—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	7.53e-05	0.00108	CcSEcCtD
Bepridil—ABCB1—cardiovascular system—type 2 diabetes mellitus	7.51e-05	0.00266	CbGeAlD
Bepridil—Nausea—Glipizide—type 2 diabetes mellitus	7.49e-05	0.00107	CcSEcCtD
Bepridil—Vision blurred—Losartan—type 2 diabetes mellitus	7.48e-05	0.00107	CcSEcCtD
Bepridil—Constipation—Gliclazide—type 2 diabetes mellitus	7.45e-05	0.00107	CcSEcCtD
Bepridil—Pain—Gliclazide—type 2 diabetes mellitus	7.45e-05	0.00107	CcSEcCtD
Bepridil—Tremor—Losartan—type 2 diabetes mellitus	7.44e-05	0.00106	CcSEcCtD
Bepridil—Rash—Glimepiride—type 2 diabetes mellitus	7.42e-05	0.00106	CcSEcCtD
Bepridil—Dermatitis—Glimepiride—type 2 diabetes mellitus	7.42e-05	0.00106	CcSEcCtD
Bepridil—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	7.41e-05	0.00106	CcSEcCtD
Bepridil—Rash—Sitagliptin—type 2 diabetes mellitus	7.4e-05	0.00106	CcSEcCtD
Bepridil—Dermatitis—Sitagliptin—type 2 diabetes mellitus	7.39e-05	0.00106	CcSEcCtD
Bepridil—Headache—Glimepiride—type 2 diabetes mellitus	7.37e-05	0.00105	CcSEcCtD
Bepridil—Cough—Irbesartan—type 2 diabetes mellitus	7.36e-05	0.00105	CcSEcCtD
Bepridil—Headache—Sitagliptin—type 2 diabetes mellitus	7.35e-05	0.00105	CcSEcCtD
Bepridil—ABCB1—kidney—type 2 diabetes mellitus	7.34e-05	0.0026	CbGeAlD
Bepridil—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	7.3e-05	0.00104	CcSEcCtD
Bepridil—ABCB1—pancreas—type 2 diabetes mellitus	7.3e-05	0.00258	CbGeAlD
Bepridil—Oedema—Metformin—type 2 diabetes mellitus	7.29e-05	0.00104	CcSEcCtD
Bepridil—Tinnitus—Ramipril—type 2 diabetes mellitus	7.29e-05	0.00104	CcSEcCtD
Bepridil—Hypertension—Irbesartan—type 2 diabetes mellitus	7.28e-05	0.00104	CcSEcCtD
Bepridil—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	7.27e-05	0.00104	CcSEcCtD
Bepridil—Insomnia—Valsartan—type 2 diabetes mellitus	7.24e-05	0.00104	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	7.21e-05	0.00103	CcSEcCtD
Bepridil—Paraesthesia—Valsartan—type 2 diabetes mellitus	7.19e-05	0.00103	CcSEcCtD
Bepridil—Myalgia—Irbesartan—type 2 diabetes mellitus	7.18e-05	0.00103	CcSEcCtD
Bepridil—Shock—Metformin—type 2 diabetes mellitus	7.18e-05	0.00103	CcSEcCtD
Bepridil—Insomnia—Orlistat—type 2 diabetes mellitus	7.16e-05	0.00102	CcSEcCtD
Bepridil—Anxiety—Irbesartan—type 2 diabetes mellitus	7.16e-05	0.00102	CcSEcCtD
Bepridil—ABCB1—cortex of kidney—type 2 diabetes mellitus	7.15e-05	0.00253	CbGeAlD
Bepridil—Dyspnoea—Valsartan—type 2 diabetes mellitus	7.14e-05	0.00102	CcSEcCtD
Bepridil—Vertigo—Losartan—type 2 diabetes mellitus	7.13e-05	0.00102	CcSEcCtD
Bepridil—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	7.13e-05	0.00102	CcSEcCtD
Bepridil—Somnolence—Valsartan—type 2 diabetes mellitus	7.12e-05	0.00102	CcSEcCtD
Bepridil—Syncope—Losartan—type 2 diabetes mellitus	7.12e-05	0.00102	CcSEcCtD
Bepridil—Paraesthesia—Orlistat—type 2 diabetes mellitus	7.11e-05	0.00102	CcSEcCtD
Bepridil—Hyperhidrosis—Metformin—type 2 diabetes mellitus	7.05e-05	0.00101	CcSEcCtD
Bepridil—Dyspepsia—Valsartan—type 2 diabetes mellitus	7.05e-05	0.00101	CcSEcCtD
Bepridil—Dizziness—Bromocriptine—type 2 diabetes mellitus	7.02e-05	0.001	CcSEcCtD
Bepridil—Dry mouth—Irbesartan—type 2 diabetes mellitus	7.02e-05	0.001	CcSEcCtD
Bepridil—Palpitations—Losartan—type 2 diabetes mellitus	7.01e-05	0.001	CcSEcCtD
Bepridil—Nausea—Glimepiride—type 2 diabetes mellitus	6.99e-05	0.001	CcSEcCtD
Bepridil—Arrhythmia—Ramipril—type 2 diabetes mellitus	6.98e-05	0.000999	CcSEcCtD
Bepridil—Loss of consciousness—Losartan—type 2 diabetes mellitus	6.98e-05	0.000998	CcSEcCtD
Bepridil—Nausea—Sitagliptin—type 2 diabetes mellitus	6.97e-05	0.000997	CcSEcCtD
Bepridil—Dyspepsia—Orlistat—type 2 diabetes mellitus	6.97e-05	0.000996	CcSEcCtD
Bepridil—Asthenia—Glyburide—type 2 diabetes mellitus	6.97e-05	0.000996	CcSEcCtD
Bepridil—Decreased appetite—Valsartan—type 2 diabetes mellitus	6.96e-05	0.000996	CcSEcCtD
Bepridil—Anorexia—Metformin—type 2 diabetes mellitus	6.95e-05	0.000994	CcSEcCtD
Bepridil—Cough—Losartan—type 2 diabetes mellitus	6.93e-05	0.000991	CcSEcCtD
Bepridil—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	6.91e-05	0.000989	CcSEcCtD
Bepridil—Abdominal pain—Gliclazide—type 2 diabetes mellitus	6.89e-05	0.000986	CcSEcCtD
Bepridil—Body temperature increased—Gliclazide—type 2 diabetes mellitus	6.89e-05	0.000986	CcSEcCtD
Bepridil—Oedema—Irbesartan—type 2 diabetes mellitus	6.88e-05	0.000984	CcSEcCtD
Bepridil—Decreased appetite—Orlistat—type 2 diabetes mellitus	6.88e-05	0.000984	CcSEcCtD
Bepridil—Constipation—Valsartan—type 2 diabetes mellitus	6.85e-05	0.00098	CcSEcCtD
Bepridil—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	6.83e-05	0.000977	CcSEcCtD
Bepridil—Shock—Irbesartan—type 2 diabetes mellitus	6.77e-05	0.000969	CcSEcCtD
Bepridil—Pain—Orlistat—type 2 diabetes mellitus	6.77e-05	0.000968	CcSEcCtD
Bepridil—Myalgia—Losartan—type 2 diabetes mellitus	6.76e-05	0.000966	CcSEcCtD
Bepridil—Anxiety—Losartan—type 2 diabetes mellitus	6.73e-05	0.000963	CcSEcCtD
Bepridil—Rash—Bromocriptine—type 2 diabetes mellitus	6.7e-05	0.000958	CcSEcCtD
Bepridil—Dermatitis—Bromocriptine—type 2 diabetes mellitus	6.69e-05	0.000957	CcSEcCtD
Bepridil—Tension—Ramipril—type 2 diabetes mellitus	6.68e-05	0.000955	CcSEcCtD
Bepridil—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	6.65e-05	0.000952	CcSEcCtD
Bepridil—Headache—Bromocriptine—type 2 diabetes mellitus	6.65e-05	0.000952	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	6.65e-05	0.00095	CcSEcCtD
Bepridil—Diarrhoea—Glyburide—type 2 diabetes mellitus	6.64e-05	0.00095	CcSEcCtD
Bepridil—ABCB1—adipose tissue—type 2 diabetes mellitus	6.62e-05	0.00234	CbGeAlD
Bepridil—Nervousness—Ramipril—type 2 diabetes mellitus	6.61e-05	0.000945	CcSEcCtD
Bepridil—Dry mouth—Losartan—type 2 diabetes mellitus	6.61e-05	0.000945	CcSEcCtD
Bepridil—Anorexia—Irbesartan—type 2 diabetes mellitus	6.56e-05	0.000938	CcSEcCtD
Bepridil—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	6.55e-05	0.000937	CcSEcCtD
Bepridil—Paraesthesia—Metformin—type 2 diabetes mellitus	6.55e-05	0.000937	CcSEcCtD
Bepridil—Dyspnoea—Metformin—type 2 diabetes mellitus	6.5e-05	0.00093	CcSEcCtD
Bepridil—Somnolence—Metformin—type 2 diabetes mellitus	6.48e-05	0.000927	CcSEcCtD
Bepridil—Oedema—Losartan—type 2 diabetes mellitus	6.48e-05	0.000926	CcSEcCtD
Bepridil—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	6.47e-05	0.000926	CcSEcCtD
Bepridil—CYP2D6—liver—type 2 diabetes mellitus	6.45e-05	0.00228	CbGeAlD
Bepridil—Dyspepsia—Metformin—type 2 diabetes mellitus	6.42e-05	0.000918	CcSEcCtD
Bepridil—Tremor—Ramipril—type 2 diabetes mellitus	6.38e-05	0.000912	CcSEcCtD
Bepridil—Shock—Losartan—type 2 diabetes mellitus	6.37e-05	0.000911	CcSEcCtD
Bepridil—Decreased appetite—Metformin—type 2 diabetes mellitus	6.34e-05	0.000907	CcSEcCtD
Bepridil—Abdominal pain—Valsartan—type 2 diabetes mellitus	6.33e-05	0.000906	CcSEcCtD
Bepridil—Nausea—Bromocriptine—type 2 diabetes mellitus	6.31e-05	0.000902	CcSEcCtD
Bepridil—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	6.3e-05	0.000901	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	6.27e-05	0.000897	CcSEcCtD
Bepridil—Hyperhidrosis—Losartan—type 2 diabetes mellitus	6.26e-05	0.000896	CcSEcCtD
Bepridil—Body temperature increased—Orlistat—type 2 diabetes mellitus	6.26e-05	0.000895	CcSEcCtD
Bepridil—Abdominal pain—Orlistat—type 2 diabetes mellitus	6.26e-05	0.000895	CcSEcCtD
Bepridil—Asthenia—Gliclazide—type 2 diabetes mellitus	6.25e-05	0.000895	CcSEcCtD
Bepridil—Constipation—Metformin—type 2 diabetes mellitus	6.24e-05	0.000892	CcSEcCtD
Bepridil—Paraesthesia—Irbesartan—type 2 diabetes mellitus	6.18e-05	0.000884	CcSEcCtD
Bepridil—Anorexia—Losartan—type 2 diabetes mellitus	6.17e-05	0.000883	CcSEcCtD
Bepridil—Dyspnoea—Irbesartan—type 2 diabetes mellitus	6.14e-05	0.000878	CcSEcCtD
Bepridil—Rash—Glyburide—type 2 diabetes mellitus	6.12e-05	0.000875	CcSEcCtD
Bepridil—Somnolence—Irbesartan—type 2 diabetes mellitus	6.12e-05	0.000875	CcSEcCtD
Bepridil—Dermatitis—Glyburide—type 2 diabetes mellitus	6.12e-05	0.000875	CcSEcCtD
Bepridil—Vertigo—Ramipril—type 2 diabetes mellitus	6.11e-05	0.000875	CcSEcCtD
Bepridil—Syncope—Ramipril—type 2 diabetes mellitus	6.1e-05	0.000873	CcSEcCtD
Bepridil—Headache—Glyburide—type 2 diabetes mellitus	6.08e-05	0.00087	CcSEcCtD
Bepridil—Dyspepsia—Irbesartan—type 2 diabetes mellitus	6.06e-05	0.000867	CcSEcCtD
Bepridil—Palpitations—Ramipril—type 2 diabetes mellitus	6.01e-05	0.00086	CcSEcCtD
Bepridil—Decreased appetite—Irbesartan—type 2 diabetes mellitus	5.98e-05	0.000856	CcSEcCtD
Bepridil—Loss of consciousness—Ramipril—type 2 diabetes mellitus	5.98e-05	0.000856	CcSEcCtD
Bepridil—Diarrhoea—Gliclazide—type 2 diabetes mellitus	5.96e-05	0.000853	CcSEcCtD
Bepridil—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	5.96e-05	0.000853	CcSEcCtD
Bepridil—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	5.94e-05	0.00085	CcSEcCtD
Bepridil—Cough—Ramipril—type 2 diabetes mellitus	5.94e-05	0.000849	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	5.9e-05	0.000844	CcSEcCtD
Bepridil—Pain—Irbesartan—type 2 diabetes mellitus	5.89e-05	0.000842	CcSEcCtD
Bepridil—Constipation—Irbesartan—type 2 diabetes mellitus	5.89e-05	0.000842	CcSEcCtD
Bepridil—Insomnia—Losartan—type 2 diabetes mellitus	5.86e-05	0.000838	CcSEcCtD
Bepridil—Paraesthesia—Losartan—type 2 diabetes mellitus	5.82e-05	0.000832	CcSEcCtD
Bepridil—Myalgia—Ramipril—type 2 diabetes mellitus	5.79e-05	0.000829	CcSEcCtD
Bepridil—Dyspnoea—Losartan—type 2 diabetes mellitus	5.78e-05	0.000826	CcSEcCtD
Bepridil—Anxiety—Ramipril—type 2 diabetes mellitus	5.77e-05	0.000826	CcSEcCtD
Bepridil—Nausea—Glyburide—type 2 diabetes mellitus	5.77e-05	0.000825	CcSEcCtD
Bepridil—Abdominal pain—Metformin—type 2 diabetes mellitus	5.77e-05	0.000825	CcSEcCtD
Bepridil—Dizziness—Gliclazide—type 2 diabetes mellitus	5.76e-05	0.000824	CcSEcCtD
Bepridil—Somnolence—Losartan—type 2 diabetes mellitus	5.76e-05	0.000824	CcSEcCtD
Bepridil—Asthenia—Valsartan—type 2 diabetes mellitus	5.75e-05	0.000822	CcSEcCtD
Bepridil—Dyspepsia—Losartan—type 2 diabetes mellitus	5.7e-05	0.000816	CcSEcCtD
Bepridil—Asthenia—Orlistat—type 2 diabetes mellitus	5.68e-05	0.000812	CcSEcCtD
Bepridil—Dry mouth—Ramipril—type 2 diabetes mellitus	5.67e-05	0.00081	CcSEcCtD
Bepridil—Decreased appetite—Losartan—type 2 diabetes mellitus	5.63e-05	0.000805	CcSEcCtD
Bepridil—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	5.63e-05	0.000805	CcSEcCtD
Bepridil—Oedema—Ramipril—type 2 diabetes mellitus	5.55e-05	0.000794	CcSEcCtD
Bepridil—Constipation—Losartan—type 2 diabetes mellitus	5.54e-05	0.000792	CcSEcCtD
Bepridil—Pain—Losartan—type 2 diabetes mellitus	5.54e-05	0.000792	CcSEcCtD
Bepridil—Rash—Gliclazide—type 2 diabetes mellitus	5.5e-05	0.000786	CcSEcCtD
Bepridil—Dermatitis—Gliclazide—type 2 diabetes mellitus	5.49e-05	0.000785	CcSEcCtD
Bepridil—Diarrhoea—Valsartan—type 2 diabetes mellitus	5.48e-05	0.000784	CcSEcCtD
Bepridil—Shock—Ramipril—type 2 diabetes mellitus	5.46e-05	0.000782	CcSEcCtD
Bepridil—Headache—Gliclazide—type 2 diabetes mellitus	5.46e-05	0.000781	CcSEcCtD
Bepridil—Abdominal pain—Irbesartan—type 2 diabetes mellitus	5.44e-05	0.000778	CcSEcCtD
Bepridil—Body temperature increased—Irbesartan—type 2 diabetes mellitus	5.44e-05	0.000778	CcSEcCtD
Bepridil—Diarrhoea—Orlistat—type 2 diabetes mellitus	5.41e-05	0.000774	CcSEcCtD
Bepridil—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	5.37e-05	0.000768	CcSEcCtD
Bepridil—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	5.3e-05	0.000758	CcSEcCtD
Bepridil—Dizziness—Valsartan—type 2 diabetes mellitus	5.3e-05	0.000758	CcSEcCtD
Bepridil—Anorexia—Ramipril—type 2 diabetes mellitus	5.29e-05	0.000757	CcSEcCtD
Bepridil—Dizziness—Orlistat—type 2 diabetes mellitus	5.23e-05	0.000749	CcSEcCtD
Bepridil—Asthenia—Metformin—type 2 diabetes mellitus	5.23e-05	0.000748	CcSEcCtD
Bepridil—Nausea—Gliclazide—type 2 diabetes mellitus	5.18e-05	0.000741	CcSEcCtD
Bepridil—Abdominal pain—Losartan—type 2 diabetes mellitus	5.12e-05	0.000732	CcSEcCtD
Bepridil—Body temperature increased—Losartan—type 2 diabetes mellitus	5.12e-05	0.000732	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	5.06e-05	0.000724	CcSEcCtD
Bepridil—Rash—Valsartan—type 2 diabetes mellitus	5.05e-05	0.000722	CcSEcCtD
Bepridil—Dermatitis—Valsartan—type 2 diabetes mellitus	5.05e-05	0.000722	CcSEcCtD
Bepridil—Insomnia—Ramipril—type 2 diabetes mellitus	5.02e-05	0.000718	CcSEcCtD
Bepridil—Headache—Valsartan—type 2 diabetes mellitus	5.02e-05	0.000718	CcSEcCtD
Bepridil—Diarrhoea—Metformin—type 2 diabetes mellitus	4.99e-05	0.000714	CcSEcCtD
Bepridil—Rash—Orlistat—type 2 diabetes mellitus	4.99e-05	0.000714	CcSEcCtD
Bepridil—Paraesthesia—Ramipril—type 2 diabetes mellitus	4.99e-05	0.000713	CcSEcCtD
Bepridil—Dermatitis—Orlistat—type 2 diabetes mellitus	4.99e-05	0.000713	CcSEcCtD
Bepridil—Headache—Orlistat—type 2 diabetes mellitus	4.96e-05	0.000709	CcSEcCtD
Bepridil—Dyspnoea—Ramipril—type 2 diabetes mellitus	4.95e-05	0.000708	CcSEcCtD
Bepridil—Asthenia—Irbesartan—type 2 diabetes mellitus	4.94e-05	0.000706	CcSEcCtD
Bepridil—Somnolence—Ramipril—type 2 diabetes mellitus	4.94e-05	0.000706	CcSEcCtD
Bepridil—Dyspepsia—Ramipril—type 2 diabetes mellitus	4.89e-05	0.000699	CcSEcCtD
Bepridil—Decreased appetite—Ramipril—type 2 diabetes mellitus	4.83e-05	0.000691	CcSEcCtD
Bepridil—Dizziness—Metformin—type 2 diabetes mellitus	4.82e-05	0.00069	CcSEcCtD
Bepridil—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	4.8e-05	0.000686	CcSEcCtD
Bepridil—Nausea—Valsartan—type 2 diabetes mellitus	4.76e-05	0.00068	CcSEcCtD
Bepridil—Constipation—Ramipril—type 2 diabetes mellitus	4.75e-05	0.000679	CcSEcCtD
Bepridil—Diarrhoea—Irbesartan—type 2 diabetes mellitus	4.71e-05	0.000674	CcSEcCtD
Bepridil—Nausea—Orlistat—type 2 diabetes mellitus	4.7e-05	0.000672	CcSEcCtD
Bepridil—Asthenia—Losartan—type 2 diabetes mellitus	4.65e-05	0.000665	CcSEcCtD
Bepridil—ABCB1—liver—type 2 diabetes mellitus	4.64e-05	0.00164	CbGeAlD
Bepridil—Rash—Metformin—type 2 diabetes mellitus	4.6e-05	0.000658	CcSEcCtD
Bepridil—Dermatitis—Metformin—type 2 diabetes mellitus	4.59e-05	0.000657	CcSEcCtD
Bepridil—Headache—Metformin—type 2 diabetes mellitus	4.57e-05	0.000654	CcSEcCtD
Bepridil—Dizziness—Irbesartan—type 2 diabetes mellitus	4.55e-05	0.000651	CcSEcCtD
Bepridil—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	4.54e-05	0.00065	CcSEcCtD
Bepridil—Diarrhoea—Losartan—type 2 diabetes mellitus	4.43e-05	0.000634	CcSEcCtD
Bepridil—Diphenhydramine—CYP1A2—type 2 diabetes mellitus	4.43e-05	0.0848	CrCbGaD
Bepridil—Abdominal pain—Ramipril—type 2 diabetes mellitus	4.39e-05	0.000628	CcSEcCtD
Bepridil—Body temperature increased—Ramipril—type 2 diabetes mellitus	4.39e-05	0.000628	CcSEcCtD
Bepridil—Rash—Irbesartan—type 2 diabetes mellitus	4.34e-05	0.000621	CcSEcCtD
Bepridil—Dermatitis—Irbesartan—type 2 diabetes mellitus	4.34e-05	0.00062	CcSEcCtD
Bepridil—Nausea—Metformin—type 2 diabetes mellitus	4.33e-05	0.00062	CcSEcCtD
Bepridil—Headache—Irbesartan—type 2 diabetes mellitus	4.31e-05	0.000617	CcSEcCtD
Bepridil—Dizziness—Losartan—type 2 diabetes mellitus	4.28e-05	0.000613	CcSEcCtD
Bepridil—Dextropropoxyphene—CYP3A4—type 2 diabetes mellitus	4.17e-05	0.0799	CrCbGaD
Bepridil—Fentanyl—CYP3A4—type 2 diabetes mellitus	4.13e-05	0.079	CrCbGaD
Bepridil—Nausea—Irbesartan—type 2 diabetes mellitus	4.09e-05	0.000585	CcSEcCtD
Bepridil—Rash—Losartan—type 2 diabetes mellitus	4.08e-05	0.000584	CcSEcCtD
Bepridil—Dermatitis—Losartan—type 2 diabetes mellitus	4.08e-05	0.000584	CcSEcCtD
Bepridil—Headache—Losartan—type 2 diabetes mellitus	4.06e-05	0.00058	CcSEcCtD
Bepridil—Asthenia—Ramipril—type 2 diabetes mellitus	3.99e-05	0.00057	CcSEcCtD
Bepridil—Nausea—Losartan—type 2 diabetes mellitus	3.85e-05	0.00055	CcSEcCtD
Bepridil—Diarrhoea—Ramipril—type 2 diabetes mellitus	3.8e-05	0.000544	CcSEcCtD
Bepridil—Dizziness—Ramipril—type 2 diabetes mellitus	3.67e-05	0.000525	CcSEcCtD
Bepridil—Benzphetamine—CYP3A4—type 2 diabetes mellitus	3.66e-05	0.07	CrCbGaD
Bepridil—Rash—Ramipril—type 2 diabetes mellitus	3.5e-05	0.000501	CcSEcCtD
Bepridil—Dermatitis—Ramipril—type 2 diabetes mellitus	3.5e-05	0.0005	CcSEcCtD
Bepridil—Phenoxybenzamine—CYP3A4—type 2 diabetes mellitus	3.5e-05	0.0669	CrCbGaD
Bepridil—Headache—Ramipril—type 2 diabetes mellitus	3.48e-05	0.000498	CcSEcCtD
Bepridil—Nausea—Ramipril—type 2 diabetes mellitus	3.3e-05	0.000472	CcSEcCtD
Bepridil—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.05e-06	1.56e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	1.04e-06	1.55e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—APOA1—type 2 diabetes mellitus	1.04e-06	1.55e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—AGT—type 2 diabetes mellitus	1.04e-06	1.55e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—AGT—type 2 diabetes mellitus	1.04e-06	1.55e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—INS—type 2 diabetes mellitus	1.04e-06	1.55e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—INS—type 2 diabetes mellitus	1.04e-06	1.55e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—AKT2—type 2 diabetes mellitus	1.04e-06	1.54e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.03e-06	1.53e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	1.03e-06	1.53e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—CALM1—type 2 diabetes mellitus	1.02e-06	1.52e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—PIK3R1—type 2 diabetes mellitus	1.02e-06	1.52e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—APOE—type 2 diabetes mellitus	1.02e-06	1.51e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—APOE—type 2 diabetes mellitus	1.02e-06	1.51e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—LPL—type 2 diabetes mellitus	1.02e-06	1.51e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—LPL—type 2 diabetes mellitus	1.02e-06	1.51e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—APOA1—type 2 diabetes mellitus	1.01e-06	1.5e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—APOA1—type 2 diabetes mellitus	1.01e-06	1.5e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—AKT2—type 2 diabetes mellitus	1.01e-06	1.49e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—AKT2—type 2 diabetes mellitus	1.01e-06	1.49e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	9.99e-07	1.48e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	9.97e-07	1.48e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	9.97e-07	1.48e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—PIK3R1—type 2 diabetes mellitus	9.89e-07	1.47e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—PIK3R1—type 2 diabetes mellitus	9.89e-07	1.47e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—SERPINE1—type 2 diabetes mellitus	9.89e-07	1.47e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	9.87e-07	1.47e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	9.87e-07	1.47e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.87e-07	1.47e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—BCL2—type 2 diabetes mellitus	9.84e-07	1.46e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	9.83e-07	1.46e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	9.72e-07	1.44e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	9.7e-07	1.44e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CCR5—type 2 diabetes mellitus	9.7e-07	1.44e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—RELA—type 2 diabetes mellitus	9.62e-07	1.43e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—SERPINE1—type 2 diabetes mellitus	9.56e-07	1.42e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—SERPINE1—type 2 diabetes mellitus	9.56e-07	1.42e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	9.55e-07	1.42e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	9.55e-07	1.42e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	9.54e-07	1.42e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—BCL2—type 2 diabetes mellitus	9.52e-07	1.41e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—BCL2—type 2 diabetes mellitus	9.52e-07	1.41e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—C3—type 2 diabetes mellitus	9.48e-07	1.41e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—NOS3—type 2 diabetes mellitus	9.44e-07	1.4e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—PIK3R1—type 2 diabetes mellitus	9.44e-07	1.4e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	9.41e-07	1.4e-05	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—AKT1—type 2 diabetes mellitus	9.38e-07	1.39e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CCR5—type 2 diabetes mellitus	9.38e-07	1.39e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	9.38e-07	1.39e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	9.34e-07	1.39e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—RELA—type 2 diabetes mellitus	9.31e-07	1.38e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—RELA—type 2 diabetes mellitus	9.31e-07	1.38e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	9.31e-07	1.38e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PPARG—type 2 diabetes mellitus	9.19e-07	1.36e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—C3—type 2 diabetes mellitus	9.17e-07	1.36e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—C3—type 2 diabetes mellitus	9.17e-07	1.36e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	9.16e-07	1.36e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—PIK3R1—type 2 diabetes mellitus	9.13e-07	1.36e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—NOS3—type 2 diabetes mellitus	9.13e-07	1.36e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—NOS3—type 2 diabetes mellitus	9.13e-07	1.36e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—PIK3R1—type 2 diabetes mellitus	9.13e-07	1.36e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—IL6—type 2 diabetes mellitus	9.08e-07	1.35e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	9.06e-07	1.35e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	9.04e-07	1.34e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IRS2—type 2 diabetes mellitus	9.01e-07	1.34e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—INS—type 2 diabetes mellitus	9.01e-07	1.34e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—AGT—type 2 diabetes mellitus	9e-07	1.34e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	8.99e-07	1.33e-05	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—AKT1—type 2 diabetes mellitus	8.96e-07	1.33e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	8.95e-07	1.33e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PPARG—type 2 diabetes mellitus	8.89e-07	1.32e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PPARG—type 2 diabetes mellitus	8.89e-07	1.32e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CALM1—type 2 diabetes mellitus	8.85e-07	1.31e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—LEP—type 2 diabetes mellitus	8.82e-07	1.31e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—APOE—type 2 diabetes mellitus	8.82e-07	1.31e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	8.8e-07	1.31e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	8.77e-07	1.3e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—IL6—type 2 diabetes mellitus	8.74e-07	1.3e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	8.74e-07	1.3e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	8.74e-07	1.3e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—APOA1—type 2 diabetes mellitus	8.72e-07	1.29e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	8.72e-07	1.29e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IRS2—type 2 diabetes mellitus	8.72e-07	1.29e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—INS—type 2 diabetes mellitus	8.72e-07	1.29e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—INS—type 2 diabetes mellitus	8.72e-07	1.29e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—AGT—type 2 diabetes mellitus	8.71e-07	1.29e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—AGT—type 2 diabetes mellitus	8.71e-07	1.29e-05	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—AKT1—type 2 diabetes mellitus	8.67e-07	1.29e-05	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—AKT1—type 2 diabetes mellitus	8.67e-07	1.29e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—PTGS2—type 2 diabetes mellitus	8.63e-07	1.28e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	8.59e-07	1.27e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CALM1—type 2 diabetes mellitus	8.56e-07	1.27e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	8.54e-07	1.27e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—APOE—type 2 diabetes mellitus	8.53e-07	1.27e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—LEP—type 2 diabetes mellitus	8.53e-07	1.27e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—APOE—type 2 diabetes mellitus	8.53e-07	1.27e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—LEP—type 2 diabetes mellitus	8.53e-07	1.27e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—IL6—type 2 diabetes mellitus	8.46e-07	1.26e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—IL6—type 2 diabetes mellitus	8.46e-07	1.26e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	8.44e-07	1.25e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	8.44e-07	1.25e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	8.43e-07	1.25e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	8.43e-07	1.25e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.38e-07	1.24e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—PTGS2—type 2 diabetes mellitus	8.35e-07	1.24e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—PTGS2—type 2 diabetes mellitus	8.35e-07	1.24e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	8.32e-07	1.23e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—IL6—type 2 diabetes mellitus	8.31e-07	1.23e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—ALB—type 2 diabetes mellitus	8.26e-07	1.23e-05	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—AKT1—type 2 diabetes mellitus	8.24e-07	1.22e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	8.16e-07	1.21e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—NFKB1—type 2 diabetes mellitus	8.11e-07	1.2e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	8.09e-07	1.2e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—AKT1—type 2 diabetes mellitus	8.07e-07	1.2e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	8.05e-07	1.19e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	8.05e-07	1.19e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	8.02e-07	1.19e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	8e-07	1.19e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—ALB—type 2 diabetes mellitus	7.99e-07	1.19e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—ALB—type 2 diabetes mellitus	7.99e-07	1.19e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	7.94e-07	1.18e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	7.9e-07	1.17e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—NOS3—type 2 diabetes mellitus	7.9e-07	1.17e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PIK3R1—type 2 diabetes mellitus	7.9e-07	1.17e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.87e-07	1.17e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—NFKB1—type 2 diabetes mellitus	7.85e-07	1.17e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—NFKB1—type 2 diabetes mellitus	7.85e-07	1.17e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—AKT1—type 2 diabetes mellitus	7.8e-07	1.16e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—AKT1—type 2 diabetes mellitus	7.8e-07	1.16e-05	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—AKT1—type 2 diabetes mellitus	7.75e-07	1.15e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	7.69e-07	1.14e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.66e-07	1.14e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—NOS3—type 2 diabetes mellitus	7.65e-07	1.13e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PIK3R1—type 2 diabetes mellitus	7.65e-07	1.13e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PIK3R1—type 2 diabetes mellitus	7.65e-07	1.13e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—NOS3—type 2 diabetes mellitus	7.65e-07	1.13e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.61e-07	1.13e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.61e-07	1.13e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—SRC—type 2 diabetes mellitus	7.56e-07	1.12e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	7.56e-07	1.12e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—INS—type 2 diabetes mellitus	7.54e-07	1.12e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	7.53e-07	1.12e-05	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—AKT1—type 2 diabetes mellitus	7.49e-07	1.11e-05	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—AKT1—type 2 diabetes mellitus	7.49e-07	1.11e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	7.45e-07	1.11e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CCL2—type 2 diabetes mellitus	7.42e-07	1.1e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—SRC—type 2 diabetes mellitus	7.31e-07	1.09e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—SRC—type 2 diabetes mellitus	7.31e-07	1.09e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—INS—type 2 diabetes mellitus	7.29e-07	1.08e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—INS—type 2 diabetes mellitus	7.29e-07	1.08e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.29e-07	1.08e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.28e-07	1.08e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	7.25e-07	1.08e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PTGS2—type 2 diabetes mellitus	7.23e-07	1.07e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	7.17e-07	1.06e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	7.17e-07	1.06e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.05e-07	1.05e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.05e-07	1.05e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.05e-07	1.05e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.05e-07	1.05e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	7.02e-07	1.04e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	7.02e-07	1.04e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PTGS2—type 2 diabetes mellitus	6.99e-07	1.04e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PTGS2—type 2 diabetes mellitus	6.99e-07	1.04e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—SRC—type 2 diabetes mellitus	6.98e-07	1.04e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	6.96e-07	1.03e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.92e-07	1.03e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—INS—type 2 diabetes mellitus	6.83e-07	1.01e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—SRC—type 2 diabetes mellitus	6.75e-07	1e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—SRC—type 2 diabetes mellitus	6.75e-07	1e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.7e-07	9.94e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.7e-07	9.94e-06	CbGpPWpGaD
Bepridil—CALM3—Immune System—EGFR—type 2 diabetes mellitus	6.63e-07	9.84e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.61e-07	9.81e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.61e-07	9.81e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	6.56e-07	9.74e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	6.44e-07	9.55e-06	CbGpPWpGaD
Bepridil—CALM2—Immune System—EGFR—type 2 diabetes mellitus	6.41e-07	9.52e-06	CbGpPWpGaD
Bepridil—CALM1—Immune System—EGFR—type 2 diabetes mellitus	6.41e-07	9.52e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.39e-07	9.49e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.39e-07	9.49e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.39e-07	9.49e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.39e-07	9.49e-06	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	6.26e-07	9.29e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—TGFB1—type 2 diabetes mellitus	6.24e-07	9.26e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—RELA—type 2 diabetes mellitus	6.22e-07	9.23e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—EGFR—type 2 diabetes mellitus	6.12e-07	9.08e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—TGFB1—type 2 diabetes mellitus	6.04e-07	8.96e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—TGFB1—type 2 diabetes mellitus	6.04e-07	8.96e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—RELA—type 2 diabetes mellitus	6.02e-07	8.93e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—RELA—type 2 diabetes mellitus	6.02e-07	8.93e-06	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	5.99e-07	8.89e-06	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	5.99e-07	8.89e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—EGFR—type 2 diabetes mellitus	5.92e-07	8.79e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—EGFR—type 2 diabetes mellitus	5.92e-07	8.79e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	5.9e-07	8.76e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	5.64e-07	8.38e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	5.64e-07	8.38e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.61e-07	8.33e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.57e-07	8.27e-06	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	5.48e-07	8.13e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.43e-07	8.06e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.43e-07	8.06e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.39e-07	8e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.39e-07	8e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.3e-07	7.87e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.25e-07	7.79e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	5.16e-07	7.66e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.14e-07	7.63e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.13e-07	7.61e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.13e-07	7.61e-06	CbGpPWpGaD
Bepridil—CALM3—Immune System—IL6—type 2 diabetes mellitus	5.09e-07	7.56e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.07e-07	7.53e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.07e-07	7.53e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.97e-07	7.38e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.97e-07	7.38e-06	CbGpPWpGaD
Bepridil—CALM2—Immune System—IL6—type 2 diabetes mellitus	4.93e-07	7.31e-06	CbGpPWpGaD
Bepridil—CALM1—Immune System—IL6—type 2 diabetes mellitus	4.93e-07	7.31e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—SRC—type 2 diabetes mellitus	4.89e-07	7.26e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.76e-07	7.07e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—SRC—type 2 diabetes mellitus	4.73e-07	7.02e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—SRC—type 2 diabetes mellitus	4.73e-07	7.02e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—IL6—type 2 diabetes mellitus	4.7e-07	6.98e-06	CbGpPWpGaD
Bepridil—CALM3—Immune System—AKT1—type 2 diabetes mellitus	4.7e-07	6.97e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.61e-07	6.84e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.61e-07	6.84e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—IL6—type 2 diabetes mellitus	4.55e-07	6.75e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—IL6—type 2 diabetes mellitus	4.55e-07	6.75e-06	CbGpPWpGaD
Bepridil—CALM2—Immune System—AKT1—type 2 diabetes mellitus	4.55e-07	6.75e-06	CbGpPWpGaD
Bepridil—CALM1—Immune System—AKT1—type 2 diabetes mellitus	4.55e-07	6.75e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.37e-07	6.49e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—AKT1—type 2 diabetes mellitus	4.34e-07	6.44e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.28e-07	6.36e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.23e-07	6.27e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.23e-07	6.27e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—AKT1—type 2 diabetes mellitus	4.2e-07	6.23e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—AKT1—type 2 diabetes mellitus	4.2e-07	6.23e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.14e-07	6.15e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.14e-07	6.15e-06	CbGpPWpGaD
Bepridil—CALM3—Metabolism—AKT1—type 2 diabetes mellitus	3.63e-07	5.39e-06	CbGpPWpGaD
Bepridil—CALM2—Metabolism—AKT1—type 2 diabetes mellitus	3.51e-07	5.22e-06	CbGpPWpGaD
Bepridil—CALM1—Metabolism—AKT1—type 2 diabetes mellitus	3.51e-07	5.22e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IL6—type 2 diabetes mellitus	3.29e-07	4.89e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IL6—type 2 diabetes mellitus	3.19e-07	4.73e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IL6—type 2 diabetes mellitus	3.19e-07	4.73e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.04e-07	4.51e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.94e-07	4.36e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.94e-07	4.36e-06	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	2.75e-07	4.09e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	2.59e-07	3.85e-06	CbGpPWpGaD
